Trial intelligence / Profile preview

Tacrolimus/Myfortic vs Tacrolimus/Sirolimus in Kidney Transplant

NCT01038505Phase 4Withdrawn

Sponsor
University of Miami
Start
Jan 2010
Primary completion
Jan 2013
Modality
Small Molecules
01

Overview

A Phase 4 trial of sirolimus in kidney transplant rejection, sponsored by University of Miami. Planned start Jan 2010; status: withdrawn.

02

Drugs

sirolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT01038505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01038505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call